Your browser doesn't support javascript.
loading
Real-life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use.
Seufert, Jochen; Freemantle, Nick; Guja, Cristian; Haluzík, Martin; Tournay, Mathilde; Vera, Carine; Bonnemaire, Mireille; Kis, Janos T.
Affiliation
  • Seufert J; Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Freemantle N; Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Guja C; Department of Diabetes, Nutrition and Metabolic Diseases, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Haluzík M; Diabetes Centre, Institute for Clinical and Experimental Medicine and Charles University, Prague, Czech Republic.
  • Tournay M; International Drug Development Institute (IDDI), Ottignies-Louvain-la-Neuve, Belgium.
  • Vera C; Ividata Life Sciences, Levallois-Perret, France.
  • Bonnemaire M; General Medicines, Sanofi, Paris, France.
  • Kis JT; Department of Internal Medicine Centrum, Szent János Hospital, Budapest, Hungary.
Diabetes Obes Metab ; 26(7): 2988-2992, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38685598
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Diabetes Mellitus, Type 2 / Insulin Glargine / Hypoglycemic Agents Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2024 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Diabetes Mellitus, Type 2 / Insulin Glargine / Hypoglycemic Agents Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2024 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido